US: Aetna, Horizon must comply with subpoenas in EpiPen antitrust suit

Aetna and Horizon Blue Cross Blue Shield of New Jersey must comply with subpoenas seeking their employees’ testimony for a lawsuit accusing Mylan NV of engaging in a scheme to squelch competition for its EpiPen allergy treatment, a federal magistrate judge has ruled.

US Magistrate Judge Teresa James in Kansas City, Kansas, on Monday, November 19, rejected the insurers’ arguments that the subpoenas from lawyers for a proposed class of consumers were unduly burdensome and sought information that could already be found in records they turned over.

Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.238.98.39

Please sign in or join us
to access premium content!